However, how the absence of TXNDC5 may influence SAA regulation under more stressful conditions like non-alcoholic fatty liver disease, fibrosis or atherosclerosis remains unclear. This evidence concerns the gene TXNDC5 and metabolic dysfunction-associated steatotic liver disease.